All Content
RDC 658/22: good manufacturing practices for medicines
Published on March 30, 2022 by Anvisa’s Collegiate Board, RDC 658 provides the general guidelines for Good Manufacturing Practices (GMP) for Medicines. The publication revoked the previous resolution of 2019, which was already a milestone for the category. In practice, RDC 658/22 does not modify the understanding of the guidelines defined in the 2019 resolution. … Continue reading “RDC 658/22: good manufacturing practices for medicines”
Read more